Ackerman - DE Pauw SRL

Ackerman - DE Pauw reported total assets of 872,575 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).

Company number (CBE) 0443.812.117 · VAT BE0443812117
8200 Bruges
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 29 Mar 1991 (≈ 35 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Ackerman - DE Pauw shows with a free account.

See the score
Profile
SRL since 1991
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result53,109 €
Equity133,983 €
Cash103,299 €
EBITDA174,681 €
Total assets872,575 €
Solvency15.4%
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +477 % Total assets -6 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Ackerman - DE Pauw's annual accounts

20252024202320222021
Net result53,109 €
Equity133,983 €
Cash103,299 €
EBITDA174,681 €
Total assets872,575 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Jul 2026
  • Year ended 31 Dec 2024filed on 30 Jul 2025
  • Year ended 31 Dec 2023filed on 21 Aug 2024
  • Year ended 31 Dec 2022filed on 18 Jul 2023
  • Year ended 31 Dec 2021filed on 28 Jul 2022

Ackerman - DE Pauw's financial analysis

Management and control of Ackerman - DE Pauw

2 active director(s) in the register.

Ackerman - DE Pauw's shareholders and holdings →

Ackerman - DE Pauw's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0443.812.117
VAT number
BE0443812117
Peppol
Registered · 0208:0443812117 · as of 10 Nov 2026
Legal form
SRL
Incorporated
29 Mar 1991
Registered office
8200 Bruges
Latest accounts
2025 · filed on 31 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Ackerman - DE Pauw (SRL) has been based in Bruges since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 53,109 € and equity of 133,983 €; its revenue is not published. Its solvency stands at 15.4%, below the median of its sector (44.2%).

Companies similar to Ackerman - DE Pauw

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Ackerman - DE Pauw

What is the revenue of Ackerman - DE Pauw?

Ackerman - DE Pauw files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Ackerman - DE Pauw?

In Belgium, the VAT number is the company number prefixed with BE: BE0443812117 for Ackerman - DE Pauw, if the company is VAT-registered. Its company number (CBE) is 0443.812.117.

Where is the registered office of Ackerman - DE Pauw?

According to the CBE register, the registered office of Ackerman - DE Pauw is in 8200 Bruges.

What is the equity of Ackerman - DE Pauw?

At the close of the 2025 financial year, the equity of Ackerman - DE Pauw amounts to 133,983 €, a solvency of 15.4% of total assets.

Who manages Ackerman - DE Pauw?

The register lists 2 active mandates at Ackerman - DE Pauw. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Ackerman - DE Pauw

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 06 Aug 2026

No credit card, no commitment.

What each plan unlocks →